[Edaily Starin Reporter Gim Ga Yeong ] Basketball player Lee Kwan-hee and influencer Yoo Si-eun, both cast members of Netflix’s dating reality show “Solo Hell 3,” are dating. Lee Kwan-hee (left) and Yoo Si-eun (Photo: Social Media)On the 29th, Lee Kwan-hee and Yoo Si-eun announced their relationship via their respective social media accounts, stating, “Today, we would like to personally share some happy news regarding the two of us.” They added, “Amid the warm support and interest shown by so many people, we have been quietly getting to know each other, and now we’ve decided to reach out to you directly to express our sincere feelings.” The couple added, “We plan to continue cherishing and supporting each other as we nurture our beautiful relationship,” and asked, “We ask for your continued interest and warm support.” The couple met while co-starring in the Netflix series *Solo Hell 3*, which premiered in December 2023. Although they were each involved with different partners during the show, they have since become a couple after the series ended, drawing significant attention. Lee Kwan-hee is a basketball player for the Seoul Samsung Thunder of the Korean Basketball League (KBL). He gained attention for his outstanding skills, including ranking first in free throw percentage during the 2018–2019 and 2021–2022 seasons. Since appearing on “Single’s Inferno 3,” he has also been active in television. He is currently starring in the Wavve Original series “Game of Blood 3.” Yoo Si-eun rose to fame after being crowned Miss Korea Sun in 2022. Since appearing on “Single’s Inferno 3,” she has been active as an influencer.
Business leaders from South Korea and Brazil have agreed to expand cooperation across a wide range of strategic industries, from critical mineral supply chains to artificial intelligence (AI), biotech…
Ingenia Therapeutics (Ingenia), an innovative antibody drug developer set to list on KOSDAQ, has brought a treatment for chronic kidney disease (CKD) to the negotiating table with a global big pharma …
Bae Yo-han, Head of Clinical Development at KANGSTEM BIOTECH CO., LTD., is presenting at a briefing on the results of the Oscar Phase 2a clinical trial held at the FKI Tower in Yeouido, Seoul, on the …